195 related articles for article (PubMed ID: 23249700)
1. Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production.
Zhang QM; Song WQ; Li YJ; Qian J; Zhai AX; Wu J; Li AM; He JM; Zhao JY; Yu X; Wei LL; Zhang FM
Virol J; 2012 Dec; 9():312. PubMed ID: 23249700
[TBL] [Abstract][Full Text] [Related]
2. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
Liu H; Li M; Song Y; Xu W
Front Immunol; 2018; 9():2479. PubMed ID: 30410495
[TBL] [Abstract][Full Text] [Related]
3. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling.
Mukherjee A; Morosky SA; Delorme-Axford E; Dybdahl-Sissoko N; Oberste MS; Wang T; Coyne CB
PLoS Pathog; 2011 Mar; 7(3):e1001311. PubMed ID: 21436888
[TBL] [Abstract][Full Text] [Related]
4. Enterovirus 2Apro targets MDA5 and MAVS in infected cells.
Feng Q; Langereis MA; Lork M; Nguyen M; Hato SV; Lanke K; Emdad L; Bhoopathi P; Fisher PB; Lloyd RE; van Kuppeveld FJ
J Virol; 2014 Mar; 88(6):3369-78. PubMed ID: 24390337
[TBL] [Abstract][Full Text] [Related]
5. c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3.
Buskiewicz IA; Koenig A; Roberts B; Russell J; Shi C; Lee SH; Jung JU; Huber SA; Budd RC
PLoS One; 2014; 9(5):e96156. PubMed ID: 24816846
[TBL] [Abstract][Full Text] [Related]
6. Transfection of prion protein gene suppresses coxsackievirus B3 replication in prion protein gene-deficient cells.
Nakamura Y; Sakudo A; Saeki K; Kaneko T; Matsumoto Y; Toniolo A; Itohara S; Onodera T
J Gen Virol; 2003 Dec; 84(Pt 12):3495-3502. PubMed ID: 14645931
[TBL] [Abstract][Full Text] [Related]
7. Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication.
Wessely R; Klingel K; Knowlton KU; Kandolf R
Circulation; 2001 Feb; 103(5):756-61. PubMed ID: 11156890
[TBL] [Abstract][Full Text] [Related]
8. Type III interferons are expressed by Coxsackievirus-infected human primary hepatocytes and regulate hepatocyte permissiveness to infection.
Lind K; Svedin E; Utorova R; Stone VM; Flodström-Tullberg M
Clin Exp Immunol; 2014 Sep; 177(3):687-95. PubMed ID: 24773058
[TBL] [Abstract][Full Text] [Related]
9. FUS/TLS Suppresses Enterovirus Replication and Promotes Antiviral Innate Immune Responses.
Xue YC; Ng CS; Mohamud Y; Fung G; Liu H; Bahreyni A; Zhang J; Luo H
J Virol; 2021 May; 95(12):. PubMed ID: 33827951
[TBL] [Abstract][Full Text] [Related]
10. A Kidnapping Story: How Coxsackievirus B3 and Its Host Cell Interact.
Peischard S; Ho HT; Theiss C; Strutz-Seebohm N; Seebohm G
Cell Physiol Biochem; 2019; 53(1):121-140. PubMed ID: 31230428
[TBL] [Abstract][Full Text] [Related]
11. CVB3 Nonstructural 2A Protein Modulates SREBP1a Signaling via the MEK/ERK Pathway.
Wang L; Xie W; Zhang L; Li D; Yu H; Xiong J; Peng J; Qiu J; Sheng H; He X; Zhang K
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258014
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
13. CVB3-Mediated Mitophagy Plays an Important Role in Viral Replication
Oh SJ; Lim BK; Yun J; Shin OS
Front Cell Infect Microbiol; 2021; 11():704494. PubMed ID: 34295842
[TBL] [Abstract][Full Text] [Related]
14. Manassantin B shows antiviral activity against coxsackievirus B3 infection by activation of the STING/TBK-1/IRF3 signalling pathway.
Song JH; Ahn JH; Kim SR; Cho S; Hong EH; Kwon BE; Kim DE; Choi M; Choi HJ; Cha Y; Chang SY; Ko HJ
Sci Rep; 2019 Jun; 9(1):9413. PubMed ID: 31253850
[TBL] [Abstract][Full Text] [Related]
15. Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice.
Koestner W; Spanier J; Klause T; Tegtmeyer PK; Becker J; Herder V; Borst K; Todt D; Lienenklaus S; Gerhauser I; Detje CN; Geffers R; Langereis MA; Vondran FWR; Yuan Q; van Kuppeveld FJM; Ott M; Staeheli P; Steinmann E; Baumgärtner W; Wacker F; Kalinke U
PLoS Pathog; 2018 Aug; 14(8):e1007235. PubMed ID: 30075026
[TBL] [Abstract][Full Text] [Related]
16. Enhanced enteroviral infectivity via viral protease-mediated cleavage of Grb2-associated binder 1.
Deng H; Fung G; Shi J; Xu S; Wang C; Yin M; Hou J; Zhang J; Jin ZG; Luo H
FASEB J; 2015 Nov; 29(11):4523-31. PubMed ID: 26183772
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
18. A Crucial Role of ACBD3 Required for Coxsackievirus Infection in Animal Model Developed by AAV-Mediated CRISPR Genome Editing Technique.
Shin HJ; Ku KB; Kim S; Kim HS; Kim YS; Kim BT; Kim SJ; Kim C
Viruses; 2021 Feb; 13(2):. PubMed ID: 33546322
[TBL] [Abstract][Full Text] [Related]
19. [Short interfering RNA-mediated inhibition of coxsakievirus B3 infection in vitro].
Han JS; Xiao ZH; Yao HL; Ren HY; Liu ZW
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):150-2. PubMed ID: 17653320
[TBL] [Abstract][Full Text] [Related]
20. Expression Profile and Function Analysis of Long Non-coding RNAs in the Infection of Coxsackievirus B3.
Tong L; Qiu Y; Wang H; Qu Y; Zhao Y; Lin L; Wang Y; Xu W; Zhao W; He H; Zhao G; Zhang MH; Yang D; Ge X; Zhong Z
Virol Sin; 2019 Dec; 34(6):618-630. PubMed ID: 31388922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
